Document Detail

Osteoarthritis: aging of matrix and cells--going for a remedy.
MedLine Citation:
PMID:  17305510     Owner:  NLM     Status:  MEDLINE    
It has been known for a very long time that aging is the most prominent risk factor for the initiation and progression of osteoarthritis. This might be related to continuous mechanical wear and tear and/or result from time/age-related modifications of cartilage matrix components. Also a mere loss of viable cells over time, due to apoptosis or any other mechanism, might contribute. More recent evidence, however, supports that stressful conditions for the cells might promote chondrocyte senescence and might be in particular important for the progression of the osteoarthritic disease process. One of the most important implications of this hypothesis is that it points to issues of cellular degeneration as the basis for understanding of the initiation and the progression of osteoarthritis. Equally important, it emphasizes that whatever treatment we envisage for osteoarthritis, we must take into account that we are dealing with aged/(pre)senescent cells which no longer have the abilities of their juvenile counterparts to respond to the many mechanical, inflammatory, and traumatic assaults to the tissue. Thirdly, this directs treatment options to deal with the senescence of cells, which are only conceptually available today. Clearly, if accumulation of wear and tear over time is the major scenario of osteoarthritis, any therapy will largely be hopeless as moving and loading the joints is unavoidable as implication of their use. However, this review intends to open up the idea that age-related changes are less a fate, but rather a challenge for therapeutic intervention which can be taken.
T Aigner; J Haag; J Martin; J Buckwalter
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current drug targets     Volume:  8     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-19     Completed Date:  2007-05-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  325-31     Citation Subset:  IM    
Institute of Pathology, University of Leipzig, Liebigstr. 26, D-04301 Leipzig, FRG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cartilage, Articular / metabolism,  pathology
Cell Aging*
Chondrocytes / metabolism,  pathology
Extracellular Matrix / metabolism,  pathology*
Glycosylation End Products, Advanced / metabolism
Middle Aged
Osteoarthritis / pathology*
Reg. No./Substance:
0/Glycosylation End Products, Advanced

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of cathepsin K in normal joints and in the development of arthritis.
Next Document:  Cell death and apoptosis in osteoarthritic cartilage.